Moreover, recent evidence demonstrated that Mecp2 targets KCC2, and neurons differentiated from induced pluripotent stem cells from patients with Rett syndrome showed a reduced expression of KCC2 and a delayed switch in the excitatory to inhibitory responses to GABA during development (Tang et al., 2016). This evidence concerns the gene MECP2 and atypical Rett syndrome.